Business Wire

Prima Solutions Strengthens Its Software Offering by Acquiring Tricast, Expert in Data Analysis Solutions and Predictive Algorithms for the Insurance Industry

Del

In accordance with its ambitious international development strategy and with the support of The Carlyle Group, its new shareholder, Prima Solutions, French insurance software vendor, today announced the acquisition of Tricast, a company specialized in analysis and predictive tools.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171016005025/en/

Based in Paris and created in 2000 by Jean Boudy, Tricast partners with nearly 50 clients across a variety of countries in Europe, South America, the Middle East and Asia, offering them access to an fully-integrated insurance analysis software platform comprised of data and predictive algorithms and aimed at improving the market position and technical margins of its end users.

This acquisition will allow Prima Solutions to enrich its software offering and to market this customized technological and scientific capability, designed to optimize the results and operational efficiency of clients. On an international scale, this acquisition gives Prima Solutions the possibility of successfully reaching new markets within Europe, the Middle East, Latin America and Asia.

The merger of these 2 software platforms also strengthens Prima Solutions’ capacity to provide an insurance solution adapted to new on-demand insurance products linked to behavioral trends (such as ‘Pay how you drive’ and usage-based policies) and based on connected solutions. This capability is enabled by actuarial analysis of big data.

Following this acquisition, Tricast’s personnel will be fully employed by Prima Solutions and will be managed by the current executive team, including the President Hugues Delannoy, as well as the CEO Rodolphe Peim.

This agreement concluded with Prima Solutions has the objective of opening up a full-service digital software platform to insurance professionals, able to meet their operational needs, including the improvement of client relations, insurance policy management and claims handling, and, in addition, optimizing technical margins. Our clients will naturally continue to benefit from the same level of quality as they have up to now and will furthermore have access to Prima Solutions’ capabilities and innovative products,” stated Jean Boudy, Founder and CEO of Tricast.

We are delighted to welcome Tricast into the Prima Solutions group. This strategic match enables us to greatly strengthen our software offer while proposing a complementary expertise to our clients, which is central to the improvement of technical margins. This acquisition demonstrates our determination to pursue our new growth strategy, particularly on an international scale by targeting new markets beyond our initial borders, with the support of our new shareholder,” adds Hugues Delannoy, President of Prima Solutions.

The acquisition of Prima Solutions in partnership with its management team has now been finalized. The investment was made by Carlyle Europe Technology Partners III, a €657 million Carlyle fund focused on European technology, media and telecommunications (TMT) companies.

***

About Tricast
In order to improve the competitiveness and technical margins of insurers, banks, cooperatives and wholesalers, Tricast provides a range of analytical and simulation tools, which are technically innovative, scientifically sophisticated and easy to use:

  • Business monitoring, profit centre follow-up, business simulations, stress scenarios
  • Report generation, Insurance specific on-line dashboard with key performance indicators
  • Risks and clients segmentation, Cross and Up selling, Lapse rate reduction
  • Actuarial tools for pricing and reserving
  • Reinsurance optimization
  • Stimulations tools to analyse the consequences of decisions
  • Fraud detection

The Tricast software is used by management teams, who benefit from a comprehensive set of features and easy-to-use user interfaces. It is delivered as a single platform with a modular approach.
To learn more, visit www.tricast-group.com

About Prima Solutions

Prima Solutions delivers the software platform Property and Casualty insurers need to gain in agility and succeed in a time of rapid industry change. Full web, modular, multilingual and available in SaaS mode, Prima Insure™ addresses the whole life cycle of an insurance policy: distribution; underwriting; contract; claims and financial management. More than 20 Property and Casualty insurers, including Allianz, AXA, Société Générale Insurance, PSA Insurance, CoverLife, Galian, Groupama, Hiscox, Mutuelle des Motards or Gras Savoye Willis, have already selected Prima Insure™. Prima Solutions is a member of ACORD.
www.prima-solutions.com
Twitter: https://twitter.com/Prima_Solutions

About The Carlyle Group

The Carlyle Group (NASDAQ: CG) is a global alternative asset manager with $170 billion of assets under management across 299 investment vehicles as of June 30, 2017. Carlyle’s purpose is to invest wisely and create value on behalf of its investors, many of whom are public pensions. Carlyle invests across four segments – Corporate Private Equity, Real Assets, Global Market Strategies and Investment Solutions – in Africa, Asia, Australia, Europe, the Middle East, North America and South America. Carlyle has expertise in various industries, including: aerospace, defense & government services, consumer & retail, energy & power, financial services, healthcare, industrial, infrastructure, real estate, technology & business services, telecommunications & media and transportation. The Carlyle Group employs more than 1,550 people in 31 offices across six continents.

Web: www.carlyle.com
Videos: http://www.carlyle.com/news-room/corporate-videos_new
Tweets: http://www.twitter.com/onecarlyle
Podcasts: www.carlyle.com/about-carlyle/market-commentary

Contact information

Press contacts
Prima Solutions
Frédéric DUTREUIL, +33(0)1 70 91 13 16 / +33(0) 6 24 04 23 39
frederic.dutreuil@prima-solutions.com
or
Leslia MADUBOST, +33(0)1 70 91 24 78
leslie.madubost@prima-solutions.com
or
Steele&Holt (The Carlyle Group)
Daphne Claude & Dominic Riding
+33(0) 6 66 58 81 92 / +33(0) 6 57 48 83 24
carlyle@steeleandholt.com
or
Catherine Armstrong (The Carlyle Group)
+44(0)207 894 1632 / +44(0)7429 421 037
catherine.armstrong@carlyle.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers17.2.2018 21:00Pressemelding

Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im

CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 08:00Pressemelding

Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates

Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 18:26Pressemelding

Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a

General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 17:05Pressemelding

General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges

Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 09:03Pressemelding

Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o

Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 08:00Pressemelding

Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and